Catalogo dei prodotti della ricerca

ALFONSO, SALVATORE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.017
EU - Europa 281
AS - Asia 273
SA - Sud America 4
AF - Africa 2
Totale 1.577
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.006
SG - Singapore 115
CN - Cina 86
FI - Finlandia 71
IT - Italia 71
IN - India 65
DE - Germania 37
UA - Ucraina 32
SE - Svezia 26
BE - Belgio 13
CA - Canada 11
GB - Regno Unito 11
IE - Irlanda 7
BG - Bulgaria 6
AR - Argentina 4
IR - Iran 3
RU - Federazione Russa 3
KR - Corea 2
NL - Olanda 2
RO - Romania 2
MY - Malesia 1
PK - Pakistan 1
SC - Seychelles 1
TG - Togo 1
Totale 1.577
Salva come PNG Salva come JPEG
Città #
Chandler 141
Fairfield 123
Singapore 80
Beijing 66
Ashburn 64
Wilmington 57
Woodbridge 55
Seattle 52
Santa Clara 50
Cambridge 43
Helsinki 42
Houston 37
Rome 37
Princeton 32
Ann Arbor 31
Plano 30
Des Moines 24
New York 24
Boston 21
Brussels 13
Jacksonville 11
Lawrence 9
San Diego 9
Millbury 8
San Paolo di Civitate 8
Toronto 8
Andover 7
Dublin 7
Cagliari 6
Falkenstein 6
Sofia 6
Frankfurt am Main 5
Norwalk 5
Federal 4
Bühl 3
Dearborn 3
Milan 3
Ottawa 3
San Mateo 3
Southend 3
Florence 2
Fuzhou 2
Hefei 2
Mannheim 2
Mentana 2
Siena 2
Arnsberg 1
Auburn Hills 1
Benxi 1
Block 1
Boardman 1
Buffalo 1
Falls Church 1
Grafing 1
Guangzhou 1
Henderson 1
Hyderabad 1
Jinan 1
Kashan 1
Kish 1
Kunming 1
Leawood 1
Lomé 1
London 1
Los Angeles 1
Miami 1
Mumbai 1
Ningbo 1
Nürnberg 1
Oxford 1
Pavia 1
Petralia Sottana 1
Provo 1
Redmond 1
Shenyang 1
Simi Valley 1
Washington 1
Xuzhou 1
Yingkou 1
Totale 1.184
Salva come PNG Salva come JPEG
Nome #
A novel antimycobacterial compound acts as an intracellular iron chelator 143
In vivo potent BM635 analogue with improved drug-like properties 103
A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity 92
MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212 90
Developing Pyrrole-Derived Antimycobacterial Agents: a Rational Lead Optimization Approach 89
Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme 72
Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin 71
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors 70
Novel Analgesic/Anti-Inflammatory Agents: Diarylpyrrole Acetic Esters Endowed with Nitric Oxide Releasing Properties 70
Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection 58
Identification of a new chemical class of potent antimycobacterial compounds derived from BM 212: design, synthesis, biological evaluation and study of their mode of action. 54
New Pyrrole-based selective COX-2 inhibiting nitric oxide donors: synthesis, in vitro and in vivo evaluation 51
Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography 49
Developing New Antiinflammatory and Analgesic Agents: Design, Synthesis, Biological and harmacological Evaluation 45
New 1,5-diphenyl pyrrole derivatives as anti-inflammatory COX-2 selective compounds and their use as potential antitumoral agents. 44
Improving the solubility and the biological profile of a novel class of derivatives as selective COX-2 inhibiting nitric oxide donors 44
Analogs of BM 212: a new chemical class of antimycobacterial agents acting upon a new target 43
BM212 targets MmpL3, Gordon Research Conference on Tuberculosis Drug Development 41
Cardiovascular effects of a new NO-releasing Coxib derivative 38
Development of a novel class of derivatives as selective COX-2 inhibiting Nitric Oxide donors: improving the solubility and the biological profile 37
New 1,5 diarylpyrrole derivatives as antimycobacterial agents: Design, synthesis, biological evaluation and study of their mode of action 34
Identification of a new Chemical Class of Potent Antimycobacterial Compounds 33
BM212-derived MmpL3 inhibitors enabling new possibilities for the treatment of TB and studies of mycobacterial iron assimilation as new potential target for drug discovery 31
New heterocyclic compounds with potential activity against parasitic protozoan: Trypanosoma and Leishmania 26
Synthesis and biological evaluation of new heterocyclic derivatives with potential antimycobacterial activity: systematic approach to lead compound optimization 25
Pyrrole-based selective COX-2 inhibiting nitric oxide donors: synthesis, in vitro and in vivo evaluation 24
New Heterocyclic Compounds Targeting Trypanothyione Metabolism in Leishmania Parasites 23
null 22
BM 579: a novel pyrrole derivative with improved antimycobacterial activity 22
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents. Design, synthesis, biological evaluation and study of their mode of action 21
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors 18
New Pyrrole Derivatives as Anti-inflammatory and Analgesic Agents: Design, Synthesis and Biological Evaluation 18
Totale 1.601
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020174 0 0 0 0 0 0 30 31 25 45 34 9
2020/202195 9 8 5 12 1 3 5 10 8 15 18 1
2021/2022263 1 20 23 6 45 4 5 24 15 21 28 71
2022/2023338 79 72 4 39 32 45 2 17 26 4 16 2
2023/2024181 17 19 7 9 16 39 3 32 0 16 10 13
2024/2025193 12 56 10 18 44 45 8 0 0 0 0 0
Totale 1.601